0001415889-24-001514.txt : 20240118
0001415889-24-001514.hdr.sgml : 20240118
20240118160328
ACCESSION NUMBER: 0001415889-24-001514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240116
FILED AS OF DATE: 20240118
DATE AS OF CHANGE: 20240118
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Grant Sean
CENTRAL INDEX KEY: 0001872792
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40407
FILM NUMBER: 24541784
MAIL ADDRESS:
STREET 1: C/O VERA THERAPEUTICS, INC.
STREET 2: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001831828
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812744449
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-770-0077
MAIL ADDRESS:
STREET 1: 8000 MARINA BOULEVARD, SUITE 120
CITY: BRISBANE
STATE: CA
ZIP: 94005
4
1
form4-01182024_090121.xml
X0508
4
2024-01-16
0001831828
Vera Therapeutics, Inc.
VERA
0001872792
Grant Sean
C/O VERA THERAPEUTICS, INC.
8000 MARINA BOULEVARD, SUITE 120
BRISBANE
CA
94005
false
true
false
false
CHIEF FINANCIAL OFFICER
0
Class A Common Stock
2024-01-16
4
A
0
26250
0
A
78683
D
Class A Common Stock
5992
I
By Trust
Class A Common Stock
2816
I
By IRA
Class A Common Stock
335
I
By Roth IRA
Class A Common Stock
857
I
By Spouse's IRA
Stock Option (right to buy)
16.80
2024-01-16
4
A
0
97500
0
A
2034-01-15
Class A Common Stock
97500
97500
D
Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under the Issuer's 2021 Equity Incentive Plan. One-fourth of the RSUs vest, rounded to the nearest whole share, on each of February 20, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service through each vesting date.
Includes 2,500 shares of Class A Common Stock acquired under the Issuer's 2021 Employee Stock Purchase Plan on September 13, 2023.
1/48 of the shares subject to the stock option will vest and become exercisable on February 16, 2024, and 1/48th of the shares subject to the stock option will vest and become exercisable monthly on the same day of each month thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ Joseph R. Young, Attorney-in-Fact
2024-01-18